-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Clinically, corticosteroids are usually recommended to treat cardiac sarcoidosis with clinical symptoms
.
Recently, the heart blood vessels published on the prestigious journal JAHA the areas of disease research article, the researchers reviewed 2013 data systematically; since then, the quality and quantity of data continues to increase, people are also increasingly non-steroidal drugs The more interested
Heart blood vessels
The researchers identified the required studies from the MEDLINE, EMBASE, Cochrane Controlled Trials Register, the Cochrane Systematic Review Database and the National Institutes of Health ClinicalTrials.
gov database, and used the Scottish Intercollegiate Guidelines Network50 to rate the quality of the included studies
The researchers retrieved a total of 3,527 references, 34 of which met the inclusion criteria
.
There were no randomized trials in the included studies, and only 2 studies were rated as high-quality studies
immunity
In contrast, 21 patients did not receive corticosteroids and/or immunosuppressive therapy, but none of them improved
.
Corticosteroid treatment is related to the prevention of deterioration of left ventricular function
Prevention of corticosteroids and/or immunosuppressive therapy in patients with cardiac sarcoidosis in both cases with atrioventricular nodal conduction and recovery of left ventricular function are associated with positive outcomes
Original source:
Siavosh Fazelpour.
et al.
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review .
JAHA.
2021.
